Looking for the best growth stocks in 2026 to turbocharge your portfolio? The Fast Movers portfolio is designed as a high-octane sector ETF alternative, focusing on dynamic healthcare stocks with a sprinkle of technology exposure. With a Tradestie Score of 57.97/100 and a Diversification Score of 67.0/100, this portfolio targets capital appreciation by zeroing in on undervalued stocks in high-growth industries. Whether you're eyeing the Q1 2026 market outlook or planning long-term gains, Fast Movers offers a concentrated bet on sectors poised for innovation and expansion.
At the heart of this portfolio are two healthcare giants: Alkermes Plc (ALKS) and Amgen Inc (AMGN), holding 51.5% and 48.5% of the allocation, respectively. Alkermes (ALKS) stands out with its cutting-edge biopharmaceutical solutions, making it one of the top healthcare stocks to buy amid rising demand for novel therapies. Meanwhile, Amgen (AMGN) offers stability and growth potential with its robust pipeline and current valuation suggesting room for upside in the 2026 market outlook. These picks are complemented by a 33% technology sector allocation, balancing the portfolio with exposure to tech stocks to buy for future-proofing returns. Both companies are selected for their strong fundamentals and potential to outperform in a competitive landscape.
Tailored for aggressive growth investors, Fast Movers suits those comfortable with medium-to-high volatility and sector-specific risks like regulatory changes in healthcare or tech disruptions. Ideal for the seasoned investor or beginner investor with a high risk tolerance, this isn’t a retirement portfolio or a passive income seeker’s haven. Be mindful of market risks, including economic downturns or policy shifts impacting healthcare stocks. If you’re hunting for the best growth stocks in 2026 with a focused sector strategy, Fast Movers could be your ticket to outsized returns.